This brand name is authorized in Nigeria.
The drug HICLODOPA contains one active pharmaceutical ingredient (API):
1
|
UNII
56LH93261Y - METHYLDOPA
|
|
Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-7340 | Tablet | HICLODOPA TAB 250 mg 10x10 | HICLODOPA METHYLDOPA 250MG methyldopa 250mg excipients q.s 3106 Drugs Nigerian Products 10x10 POM 1 18/10/2022 HIGHCLOUT PHARMA LIMITED, , NOAH'S PAVILLION ESTATE OFF MOWE MOWE OGUN 8028310715 Highcloutpharma@yahoo.com ECOMED PHARMA LIMITED, Plot 32, Lynson Chemical Avenue Km 38, Lagos - Abeokuta Expressway Sango – Ota, Ogun State., Nigeria | 31/08/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C02AB01 | Methyldopa (levorotatory) | C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AB Methyldopa |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-7340 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.